Default company panoramic image

Nanofiber Solutions. Inc.

Nanofiber Solutions is a regenerative medicine company developing a new class of implants for soft tissue/organ repair/regeneration.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Columbus, OH, USA
  • Currency USD
  • Founded April 2009
  • Employees 9
  • Incorporation Type C-corp
  • Website

Company Summary

Using a platform technology we combine the benefits of synthetic (man made) and biologic (cell-based) devices while eliminating the risks inherent in each. Our technology is used to build scaffolds that are critical in the development of life-saving tissue engineered implants. We manufacture the world’s first nanofiber tracheal implant. Our products have been used in successful surgeries and we are rapidly expanding our patent estate.


  • Mr. Kayuha specializes in building start-up companies to maximize their market potential. His past includes a senior role during Claremont Technology Group’s growth from $3M to over $65M Revenues in six years; including an IPO and eventual acquisition. Ross was the CEO of Strategic Thinking Industries, a healthcare software start-up company, and has served as either CEO or advisor to many other start-ups.

  • Dr. Johnson has a PhD in Materials Science & Engineering from the Ohio State University with a focus on biomedical applications. As an inventor of our base technology, and with several years’ experience building bioengineered scaffolds, he is considered a leader in this emerging field. Because of his reputation, Dr. Johnson is the inventor of the first nanofiber tracheal implant, and he is regularly contacted for surgical device consultations.

  • 90d26a71 b37a 4e67 9795 839a5f69e573
    Chief Operating Officer

    Ronny has over 25 years of product development experience with eighteen years’ experience in regulated product development with C.R. Bard. In his most recent roles as VP of R&D and VP Strategic Initiatives he led identification, development and modifications to products that have achieved over $650M in cumulative Revenue. Mr. Bracken is considered an expert at developing regulated medical devices.


  • Default avatar
    Pepper Hamilton
    Default avatar
    Brixel & Meyer

Previous Investors

  • Default avatar